Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5α-Dihydrotestosterone PET: A Pilot StudyHeather Jacene, Mofei Liu, Su-Chun Cheng, et al.
Journal of Nuclear Medicine Technology|June 14, 2023
Report on the PET/CT Image-Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast CancerKeisha C McCall, Mofei Liu, Su-Chun Cheng, et al.
The Journal of Clinical Investigation|January 31, 2023
YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinomaThomas C Frost, Ashley K Gartin, Mofei Liu, et al.
Bioorganic Chemistry|March 16, 2023
Structural optimization of tetrahydroisoquinoline-hydroxamate hybrids as potent dual ERα degraders and HDAC inhibitorsShuangshuang Xiong, Xin Wang, Meiqi Zhu, et al.
JAMA Dermatology|April 13, 2022
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint InhibitorsJordan T Said, Mofei Liu, Jordan Talia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2025
Effect of bone marrow disease on hematologic toxicity and response to [177Lu]Lu-PSMA-617 therapy: insights from PSMA-PET/CT imagingNuno Borges, Meryam Losee, Mofei Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 15, 2026
Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable MelanomaJustine V Cohen, Mofei Liu, Grace Rogers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 21, 2025
A pilot study of [18F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomyThomas S C Ng, Mofei Liu, Matthew Robertson, et al.
The Prostate|March 19, 2025
Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center ExperienceMeryam Losee, Michael Kavanaugh, Mofei Liu, et al.
JAMA Oncology|October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical TrialKartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Pageof 3